Effects of ultra-low-dose estrogen therapy on muscle and physical function in older women

Journal of the American Geriatrics Society

Volumn 53, Issue 11, 2005, Pages 1973-1977

  Kenny, Anne M ^a   Kleppinger, Alison ^a   Wang, Yahzen ^b   Prestwood, Karen M ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Appendicular skeletal muscle mass; Physical performance; Sarcopenia; Ultra low dose estrogen therapy

Indexed keywords

CALCIUM; ESTRADIOL; ESTROGEN; PROGESTERONE; VITAMIN D;

AGED; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ELDERLY CARE; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN EXPERIMENT; LEAN BODY WEIGHT; LOW DRUG DOSE; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE MASS; NORMAL HUMAN; PHYSICAL CAPACITY; POSTMENOPAUSE;

AGED; BODY COMPOSITION; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; DENSITOMETRY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTRONE; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; MATHEMATICAL COMPUTING; MUSCLE, SKELETAL; PHYSICAL FITNESS; REFERENCE VALUES;

EID: 29244447376     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53567.x     Document Type: Article

References (40)

1. Roubenoff R, Hughes VA. Sarcopenia. Current concepts. J Gerontol A Biol Sci Med Sci 2000;55A:M716-M724.
2. Harris T. Muscle mass and strength: Relation to function in population studies. J Nutr 1997;127:1004S-1006S.
3. Douchi T, Yamamoto S, Nakamura S et al. The effect of menopause on regional and total body lean mass. Maturitas 1998;29:247-252.
4. Brown M, Birge SJ, Kohrt WM. Hormone replacement therapy does not augment gains in muscle strength or fat-free mass in response to weight-bearing exercise. J Gerontol A Biol Sci Med Sci 1997;52A:B166-B170.
5. Tankó LB, Moveseyan L, Mouritzen U et al. Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women. Metabolism 2002;51:69-74.
6. Calmels P, Vico L, Alexandre C et al. Cross-sectional study of muscle strength and bone mineral density in a population of 106 women between the ages of 44 and 87 years: Relationship with age and menopause. Eur J Appl Physiol 1995;70:180-186.
7. Taaffe DR, Luz Villa M, Delay R et al. Maximal muscle strength of elderly women is not influenced by estrogen status. Age Ageing 1995;24:329-333.
8. Ferrucci L, Guralnik JM, Buchner D et al. Departures from linearity in the relationship between measures of muscular strength and physical performance of the lower extremities: The Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 1997;52A:M275-M285.
9. Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-613.
10. Ettinger B, Grady D, Tosteson AN et al. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225-1232.
11. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: Annual trends and response to recent evidence. JAMA 2004;291:47-53.
12. Prestwood KM, Kenny AM, Unson C et al. The effect of low dose micronized 17ss-estradiol on bone turnover, sex hormone levels, and side effects in older women: A randomized, double blind, placebo-controlled study. J Clin Endocrinol Metab 2000;85:4462-4469.
13. Lufkin EG, Wahner HW, O'Fallon WM et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992;117:1-9.
14. Recker RR, Davies KM, Dowd RM et al. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women: A randomized, controlled trial. Ann Intern Med 1999;130:897-904.
15. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med 1987;106:40-45.
16. Prestwood KM, Kenny AM, Kleppinger A et al. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: A randomized controlled trial. JAMA 2003;290:1042-1048.
17. Prestwood KM, Unson C, Kulldorff M et al. The effect of different doses of micronized 17beta-estradiol on C-reactive protein, interleukin-6, and lipids in older women. J Gerontol A Biol Sci Med Sci 2004;59A:M827-M832.
18. Tanko LB, Movsesyan L, Svendsen OL et al. The effects of hormone replacement therapy on appendicular lean tissue mass in early postmenopausal women. Menopause 2002;9:117-121.
19. Gower BA, Nyman L. Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women. J Clin Endocrinol Metab 2000;85:4476-4480.
20. Baumgartner RN, Koehler KM, Gallagher D et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-763.
21. Washburn RA, Smith KW, Jette AM et al. The Physical Activity Scale for the Elderly (PASE). Development and evaluation. J Clin Epidemiol 1993;46:153-162.
22. Guralnik JM, Simonsick EM, Ferrucci L et al. A short physical performance battery assessing lower extremity function. Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:85-94.
23. Aloia JF, McGowan DM, Vaswani AN et al. The relationship of menopause to skeletal and muscle mass. Am J Clin Nutr 1991;53:1378-1383.
24. Aloia JF, Vaswasni A, Russo L et al. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 1995;3:896-900.
25. Phillips SK, Rook KM, Siddle NC et al. Muscle weakness in women occurs at an earlier age than men, but strength is preserved by hormone replacement therapy. Clin Sci 1993;84:95-98.
26. Cauley JA, Petrini AM, Laporte RE et al. The decline of grip strength in the menopause: Relationship to physical activity, estrogen use and anthropometric factors. J Chronic Dis 1987;40:115-120.
27. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;15:455-456.
28. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 2002;57A:M772-M777.
29. Kenny AM, Sucich-Iannuzzi M, Kleppinger A et al. Prevalence of sarcopenia and predictors of skeletal muscle mass in non-obese postmenopausal women on long-term estrogen therapy. J Gerontol A Biol Sci Med Sci 2003;58A:M436-M440.
30. Maddalozzo GF, Cardinal BJ, Li F et al. The association between hormone therapy use and changes in strength and body composition in early postmenopausal women. Menopause 2004;11:438-446.
31. Espeland MA, Stefanick ML, Kritz-Silverstein D et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab 1997;82:1549-1556.
32. Sipila S, Taaffe DR, Cheng S et al. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: A randomized placebo-controlled study. Clin Sci (Lond) 2001;101:147-157.
33. Redberg RF, Nishino M, McElhinney DB et al. Long-term estrogen replacement therapy is associated with improved exercise capacity in postmenopausal women without known coronary artery disease. Am Heart J 2000;139:739-744.
34. Bryner RW, Toffle RC, Ullrich IH et al. Effect of low dose oral contraceptives on exercise performance. Br J Sports Med 1996;30:36-40.
35. Uusi-Rasi K, Beck TJ, Sievanen H et al. Associations of hormone replacement therapy with bone structure and physical performance among postmenopausal women. Bone 2003;32:704-710.
36. Skelton DA, Phillips SK, Bruce SA et al. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. Clin Sci 1999;96:357-364.
37. Greeves JP, Cable NT, Luckas MJ et al. Effects of acute changes in oestrogen on muscle function of the first dorsal interosseus muscle in humans. J Physiol 1997;500:265-270.
38. Wiik A, Glenmark B, Ekman M et al. Oestrogen receptor beta is expressed in adult human skeletal muscle both at the mRNA and protein level. Acta Physiol Scand 2003;179:381-387.
39. Lemoine S, Granier P, Tiffoche C et al. Estrogen receptor alpha mRNA in human skeletal muscles. Med Sci Sports Exerc 2003;35:439-443.
40. Ciocca D, Vargas Roig LM. Estrogen receptors in human nontarget tissues. Biological and clinical implications. Endocrine Rev 1995;16:35-62.